David S. Krause

Anidulafungin versus Fluconazole for Invasive Candidiasis

Annette C. Reboli, Coleman Rotstein, Peter G. Pappas et al. · New England Journal of Medicine · 2007 · 888 citations · Full text

Vaccination against Lyme Disease with Recombinant<i>Borrelia burgdorferi</i>Outer-Surface Lipoprotein A with Adjuvant

Allen C. Steere, Vijay K. Sikand, François Meurice et al. · New England Journal of Medicine · 1998 · 738 citations · Full text

A Randomized, Double-Blind Trial of Anidulafungin versus Fluconazole for the Treatment of Esophageal Candidiasis

David S. Krause, A. E. Simjee, C.E.J. Van Rensburg et al. · Clinical Infectious Diseases · 2004 · 243 citations · Full text

Antifungal Agent, Antifungal Agents, Double-blind Trial +10

Phase 2, Randomized, Dose-Ranging Study Evaluating the Safety and Efficacy of Anidulafungin in Invasive Candidiasis and Candidemia

David S. Krause, John F. Reinhardt, José A. Vázquez et al. · Antimicrobial Agents and Chemotherapy · 2004 · 178 citations · Full text

Randomized, controlled, participant‐ and rater‐blind trial of pharmacogenomic test‐guided treatment versus treatment as usual for major depressive disorder

Roy H. Perlis, Daniel Dowd, Maurizio Fava et al. · Depression and Anxiety · 2020 · 60 citations